Chris Roberts

Christopher Graham Roberts is currently Non-Executive Director at Nutromics Pty Ltd. since 2023, Non-Executive Director at HMC Capital Partners Fund I since 2024, Independent Non-Executive Director at Sigma Healthcare Ltd. since 2023, Non-Executive Director at Atmo Biosciences Ltd., Independent Non-Executive Director at HealthCo Healthcare & Wellness REIT since 2021, Independent Non-Executive Director at HMC Capital Ltd. since 2024, Non-Executive Director at Cochlear Foundation Ltd. since 2006, Non-Executive Director at Clarity Pharmaceuticals Ltd. since 2016, Independent Non-Executive Director at HCW Funds Management Ltd., Professor at Arizona State University, Professor at The University of New South Wales, Professor at King's College London, Member-Governors Board at Centenary Institute since 2015, and Member at Innovation Australia.
Former roles include President, CEO & Executive Director at Cochlear Ltd. from 2011 to 2015, Chairman at Sirtex Medical Pty Ltd. from 2000 to 2002, Executive Chairman at OncoSil Medical Ltd. from 2020 to 2021, Chairman at Research Australia Ltd. from 2004 to 2010, Chairman at ASU London Centre for Advanced Learning from 2019 to 2023, President, Director & Executive Vice President at ResMed, Inc. from 1992 to 2017, President at BGS Medical from 1976 to 1992, and Member at National Health & Medical Research Council from 2003 to 2006.
Education includes undergraduate and doctorate degrees from The University of New South Wales and an MBA from Macquarie University.